AD is diagnosed post mortem based on the presence in brain of amyloid plaques, comprised mostly of amyloid-β (Aβ) peptides, and neurofibrillary tangles (NFTs) of hyperphosphorylated microtubule associated protein tau (MAPT). Here, MAPT is linked to Alzheimer disease.